Literature DB >> 30073798

HLA common and well-documented alleles in China.

Y He1,2, J Li3, W Mao4, D Zhang5, M Liu6, X Shan7, B Zhang8, C Zhu9, J Shen10, Z Deng11, Z Wang12, W Yu13, Q Chen14, W Guo15, P Su16, R Lv17, G Li19, G Li19, B Pei20, L Jiao21, G Shen22, Y Liu23, Z Feng24, Y Su25, Y Xie26, W Di27, X Liu28, X Yang29, J Wang14, J Qi6, Q Liu30, Y Han30, J He31, J Cai32,33, Z Zhang7, F Zhu1,2, D Du30.   

Abstract

The American Society for Histocompatibility and Immunogenetics HLA common and well-documented (CWD) catalog, CWD 2.0.0 catalog and European Federation for Immunogenetics (EFI) CWD catalog have been published, which are useful for improving the accuracy of HLA genotyping in laboratories. Here, we studied the Chinese HLA CWD catalog. A total of 812 211 unrelated volunteer donors from the China Marrow Donor Program (CMDP) were analyzed. Six hundred seventy-six alleles at the HLA-A, -B, -C, -DRB1, and -DQB1 loci were defined as CWD alleles in the Chinese population, including 159 common and 517 well-documented alleles. The distribution of HLA alleles in the Chinese CWD catalog is different from that in the EFI CWD catalog. Thirty-two percent (215/676) of CWD alleles in the Chinese CWD catalog are shared with those in the EFI CWD catalog. Fifty-six percent (380/676) of alleles in the Chinese CWD catalog are not found in the EFI CWD catalog, while 655 alleles in the EFI CWD catalog are neither common nor well-documented alleles in the Chinese CWD catalog. The Chinese CWD catalog described in this study may help to improve high-resolution histocompatibility testing for CMDP-accredited laboratories in China. However, to accommodate an increasing number of HLA alleles, this Chinese CWD catalog should be regularly updated.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ASHI; Chinese population; EFI; HLA; common and well-documented allele

Mesh:

Substances:

Year:  2018        PMID: 30073798     DOI: 10.1111/tan.13358

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  17 in total

1.  Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules.

Authors:  Sahil Jain; Manoj Baranwal
Journal:  Med Microbiol Immunol       Date:  2019-02-21       Impact factor: 3.402

2.  The deduced probable HLA-C*03:187-associated human leukocyte antigen haplotype (A*24:02-B*35:01-C*03:187-DRB1*11:01) revealed in Taiwanese unrelated hematopoietic bone marrow stem cell donors.

Authors:  Kuo-Liang Yang; Py-Yu Lin
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-30

3.  Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants.

Authors:  Chao Hu; Meiying Shen; Xiaojian Han; Qian Chen; Luo Li; Siyin Chen; Jing Zhang; Fengxia Gao; Wang Wang; Yingming Wang; Tingting Li; Shenglong Li; Jingjing Huang; Jianwei Wang; Ju Zhu; Dan Chen; Qingchen Wu; Kun Tao; Da Pang; Aishun Jin
Journal:  Genes Dis       Date:  2021-06-29

4.  The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients.

Authors:  Xinyu Wu; Jialing Wu; Xiaomin Li; Qiujing Wei; Qing Lv; Pingping Zhang; Xuqi Zheng; Zena Chen; Shuangyan Cao; Liudan Tu; Jieruo Gu
Journal:  Front Med (Lausanne)       Date:  2021-01-08

5.  Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.

Authors:  Mullin Ho Chung Yu; Marcus Chun Yin Chan; Claudia Ching Yan Chung; Andrew Wang Tat Li; Chara Yin Wa Yip; Christopher Chun Yu Mak; Jeffrey Fong Ting Chau; Mianne Lee; Jasmine Lee Fong Fung; Mandy Ho Yin Tsang; Joshua Chun Ki Chan; Wilfred Hing Sang Wong; Jing Yang; William Chun Ming Chui; Patrick Ho Yu Chung; Wanling Yang; So Lun Lee; Godfrey Chi Fung Chan; Paul Kwong Hang Tam; Yu Lung Lau; Clara Sze Man Tang; Kit San Yeung; Brian Hon Yin Chung
Journal:  PLoS Genet       Date:  2021-02-18       Impact factor: 5.917

6.  SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response.

Authors:  Chanchan Xiao; Lipeng Mao; Zhigang Wang; Lijuan Gao; Guodong Zhu; Jun Su; Xiongfei Chen; Jun Yuan; Yutian Hu; Zhinan Yin; Jun Xie; Weiqing Ji; Haitao Niu; Feng Gao; Oscar Junhong Luo; Lianbo Xiao; Pengcheng Wang; Guobing Chen
Journal:  iScience       Date:  2022-02-17

7.  Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein.

Authors:  Yunwen Zhang; Zhengrong Yang; Mingyuan Tang; Hao Li; Tian Tang; Guilian Li; Yifan Zhong; Xiaomin Zhang; Xiaohui Wang; Chuan Wang
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

8.  Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0.

Authors:  Carolyn K Hurley; Jane Kempenich; Kim Wadsworth; Jürgen Sauter; Jan A Hofmann; Daniel Schefzyk; Alexander H Schmidt; Pablo Galarza; Maria B R Cardozo; Malgorzata Dudkiewicz; Lucie Houdova; Pavel Jindra; Betina S Sorensen; Latha Jagannathan; Ankit Mathur; Tiina Linjama; Tigran Torosian; Rafi Freudenberger; Anastasios Manolis; John Mavrommatis; Nezih Cereb; Sigal Manor; Nira Shriki; Nicoletta Sacchi; Reem Ameen; Raewyn Fisher; Heather Dunckley; Irene Andersen; Ahmed Alaskar; Mohsen Alzahrani; Ali Hajeer; Dunia Jawdat; Grazia Nicoloso; Pawinee Kupatawintu; Louise Cho; Ashminder Kaur; Mats Bengtsson; Jason Dehn
Journal:  HLA       Date:  2020-01-31       Impact factor: 4.513

9.  Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).

Authors:  Wei Wang; Wei Zhang; Jingjing Zhang; Ji He; Faming Zhu
Journal:  HLA       Date:  2020-06-02       Impact factor: 8.762

10.  CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2.

Authors:  Congling Qiu; Chanchan Xiao; Zhigang Wang; Guodong Zhu; Lipeng Mao; Xiongfei Chen; Lijuan Gao; Jieping Deng; Jun Su; Huanxing Su; Evandro Fei Fang; Zhang-Jin Zhang; Jikai Zhang; Caojun Xie; Jun Yuan; Oscar Junhong Luo; Li An Huang; Pengcheng Wang; Guobing Chen
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.